Health News Releases

  • Today May 19
February 19, 2018 11:20
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers
Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented i
February 19, 2018 11:15
OTEZLA® (Apremilast) Phase II Data Showed Clinically Meaningful Improvements in Patients with Active Ulcerative Colitis
Celgene Corporation (NASDAQ:CELG) announced that data from a randomized, placebo-controlled, multi-center, phase II clinical trial of apremilast in patients with active ulcerative colitis who had fail
February 19, 2018 10:55
New Genome Study of B. longum subsp. longum by Morinaga Milk May Explain the Species' Wide Distribution across All Ages
Bifidobacterium longum is one of only a handful of species of gut bacteria that is widely present among people of all ages, including infants, adults and the elderly.[1,2] Today, Morinaga Milk Industr
February 15, 2018 11:00
Ferring Announces 30 Million CHF Investment in New Biotech Centre in Switzerland
Ferring Pharmaceuticals announced today that it is expanding its capabilities in biologics through a new biotech centre which will be installed at the company’s existing headquarters and manufacturing
February 14, 2018 16:00
World Patient Safety Summit Aims to Reduce Unnecessary C-Sections
Two survivors of C-section delivery and postpartum complications will be part of a distinguished panel at the upcoming 2018 World Patient Safety Science & Technology Summit in London, on Saturday, Feb
February 13, 2018 11:50
New Study Evaluates the Performance of Masimo PVi® as a Predictor of Fluid Responsiveness in Mechanically Ventilated ICU Patients
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Bülent Ecevit University in Zonguldak, Turkey compared two noninvasive methods of predicting fl
February 09, 2018 14:05
6th Annual World Patient Safety, Science & Technology Summit Is SOLD OUT!
Thanks to overwhelming demand to hear the latest advances in patient safety, registration for the 6th Annual World Patient Safety, Science and Technology Summit is now closed. In order to make sure th
February 09, 2018 10:20
Agilent to Support Korea Doping Control Center
Agilent Technologies Inc. (NYSE:A) today announced it will collaborate with the Doping Control Center in Seoul, South Korea, to ensure that athletes from around the world are quickly and accurately te
February 08, 2018 17:50
Gluco-Chaser™ Inc. Announces Disposable Glucose Sensor Results with Non-Enzymatic Electrochemistry
Gluco-ChaserTM Inc. is pleased to announce that its disposable strip BGM (blood glucose monitoring) prototype sensor with non-enzymatic electrochemistry achieved a 5-second glucose reading from human
February 08, 2018 15:45
Masimo Announces CE Marking of Eve™ CCHD Newborn Screening Application for the Rad-97™ Pulse CO-Oximeter®
Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse CO-Oximeter®. Eve combines the power of Ma
February 06, 2018 11:45
“‘Someday’ is Now!”: Anpac Bio & Med Partners Celebrate ‘National Cancer Prevention Month’ Surpassing 60,000 ‘Liquid Biopsy’ Cases
Anpac Bio-Medical Science Company (Anpac Bio), and its internationally-acclaimed medical research partners and hospitals, are celebrating “World Cancer Day” (#WorldCancerDay) and “National Cancer Prev
February 05, 2018 11:35
Takeda Reports 3rd Quarter FY2017 Results
Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth +6.7% led by Takeda's Growth Drivers · Underlying Revenue grew +6.7% year-to-date, with Takeda's Growth Drivers (Gas
February 02, 2018 18:40
PharmAbcine Enters Collaboration with MSD Focused on Clinical Evaluation of TTAC-0001 in Combination with KEYTRUDA® (pembrolizumab) in Recurrent Glioblastoma and Breast Cancer
PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications, announces it has entered into a collaborative agreement with MSD (tradename o
February 02, 2018 16:55
World Health Organization Director-General to Deliver Keynote at Patient Safety Summit
Global leaders, patient safety experts, hospital and medical technology CEOs and patient advocates will gather to address the challenges that cause medical errors and preventable deaths in hospitals w
January 31, 2018 17:10
Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAK-426, Takeda’s purified, inactiv
January 26, 2018 16:00
Ferring Announces Recipients of Innovation Grants Program 2017-2018
Ferring Pharmaceuticals today announced the recipients of the 2017-2018 Innovation Grants Program, an annual initiative of the Ferring Research Institute (FRI) based in San Diego. This global program
January 24, 2018 15:55
European Commission Approves ADCETRIS® (brentuximab vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma after One Prior Systemic Therapy- Providing an Innovative Treatment Option to Patients
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission (EC) extended the current conditional marketing authorization of ADCETRIS® (brentuximab vedotin) and appr
January 24, 2018 11:25
Takeda Recognized as a Global 100 Most Sustainable Corporation for Third Consecutive Year
Takeda Pharmaceutical Company Limited [TOKYO:4502], (“Takeda”) is proud to be named by Corporate Knights as one of the 2018 Global 100 Most Sustainable Corporations in the World (Global 100) for the t
January 23, 2018 11:35
Octapharma: Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A
Octapharma is delighted to announce the publication of final data from a Good Clinical Practice (GCP) trial in PUPs in the internationally renowned medical journal Haemophilia. The study assessed the
January 23, 2018 11:05
New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients
Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the annual meeting of the Society for Technology in Anesthesia (STA) in Miami, Florida. In the study, researchers at the
January 23, 2018 09:25
Ferring enters into worldwide OmniAb® platform license agreement with Ligand
Ferring Pharmaceuticals announced today that it has entered into a worldwide license agreement with Ligand Pharmaceuticals to use Ligand’s OmniAb platform® to discover new human monoclonal antibodies
January 18, 2018 16:00
AMR Industry Alliance: Report Shows Life Sciences Industry Alliance is Taking Action to Curb Antimicrobial Resistance, with More to Come
Today, the AMR Industry Alliance launches its first report that shows the commitment of the life sciences industry to tackle the public health threat of antimicrobial resistance (AMR). The Alliance br
January 18, 2018 13:40
Premas, IncellDx Ink India Distribution Agreement
Premas Life Sciences Pvt., Ltd. and IncellDx, Inc. announced today they have signed an exclusive distribution agreement. The commercial partnership brings the power of cell by cell multiplex diagnosti
January 18, 2018 13:30
President Clinton to Address Healthcare Leaders Focused on Eliminating Preventable Deaths in Hospitals at the 6th Annual World Patient Safety, Science & Technology Summit
For the 6th year in a row, President Bill Clinton, the Founder of the Clinton Foundation and 42nd President of the United States, will deliver keynote remarks at the 6th Annual World Patient Safety, S
January 12, 2018 14:30
Herbalife Nutrition Enhances Personalized Nutrition Program with Launch of Gene Start in South Korea
With the goal of helping people live healthier and happier, Herbalife Nutrition today launched Gene Start in South Korea, the first of its markets in the world to introduce an innovative healthcare se
25 per page50 per page75 per page100 per page